| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff283c7d6797987f01db547f606e6b32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7970e52ae37d06074d5f8d1b8a857bf5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-487 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37 |
| filingDate |
2016-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f99b6bd55f2e2c63105414f5c0c5f8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6901318fdf3570f000056dc85bc08766 |
| publicationDate |
2018-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101833430-B1 |
| titleOfInvention |
Pharmaceutical composition for prevention or treatment of diabetic nephropathy by bakuchiol, psoralen or isopsoralen |
| abstract |
The present invention relates to a pharmaceutical composition for the prevention and treatment of diabetic nephropathy which comprises as an active ingredient bakuchiol, psoralen or isopsoralen. More particularly, the present invention relates to a pharmaceutical composition for preventing and treating diabetic nephropathy, , It was confirmed that diabetic nephropathy was improved by inhibiting apoptosis of renal vascular endothelial cell line and the anti-fibrosis effect of renal glomeruli. Therefore, it was confirmed that the above-mentioned vanutiol, , And bovine extract may be used as pharmaceutical compositions for the prevention or treatment of diabetic nephropathy. |
| priorityDate |
2016-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |